相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
Arun Kumar Attuluri et al.
BMC CANCER (2019)
Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients
Manjiri M. Bakre et al.
CANCER MEDICINE (2019)
Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice
Elsa Curtit et al.
BREAST (2019)
Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016
Rajesh Sharma
BREAST CANCER (2019)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016
Preet K. Dhillon et al.
LANCET ONCOLOGY (2018)
Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor-Positive Breast Cancer
Charusheila Ramkumar et al.
BIOMARKER INSIGHTS (2018)
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study
Anne Kuijer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Epidemiology of breast cancer in Indian women
Shreshtha Malvia et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
Matteo Lambertini et al.
BRITISH JOURNAL OF CANCER (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
Cindy Farquhar et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ≤40 years at breast cancer diagnosis
T. Maishman et al.
BRITISH JOURNAL OF CANCER (2015)
Breast Cancer Disparities: A Multicenter Comparison of Tumor Diagnosis, Characteristics, and Surgical Treatment in China and the US
Priya G. Sivasubramaniam et al.
ONCOLOGIST (2015)
Chemotherapy in Early Breast Cancer: When, How and Which One?
Marcus Schmidt
BREAST CARE (2014)
Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models
Ellen G. Engelhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK
S. Holt et al.
BRITISH JOURNAL OF CANCER (2013)
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
Berit Maria Mueller et al.
PLOS ONE (2013)
Prognostic utility of HOXB13: IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
P-L Jerevall et al.
BRITISH JOURNAL OF CANCER (2011)
A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
Martin Filipits et al.
CLINICAL CANCER RESEARCH (2011)
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival
Fatemeh Asadzadeh Vostakolaei et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2011)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
Shelly S. Lo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
Gordon C. Wishart et al.
BREAST CANCER RESEARCH (2010)
Breast cancer care in India: The current scenario and the challenges for the future
Gaurav Agarwal et al.
BREAST CARE (2008)
The Half Century of Clinical Trials of the National Surgical Adjuvant Breast and Bowel Project
D. Lawrence Wickerham et al.
SEMINARS IN ONCOLOGY (2008)
Breast Cancer in Chinese Women Younger than Age 40: Are They Different from Their Older Counterparts?
Ava Kwong et al.
WORLD JOURNAL OF SURGERY (2008)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
PM Ravdin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
